Koneksa Insights
Latest Blog Posts
Focus on Biomarker vs. eCOA
Koneksa’s unique expertise in designing, developing, and deploying digital health technology (DHT)-enabled biomarkers in clinical trials, and our experience analyzing the corresponding data, can provide value to your product’s journey….
DownloadSmall But Mighty: ASCPT Convenes Discussion of Innovative Clinical Trial Designs in Small Patient Populations
This week, the American Society of Clinical Pharmacology and Therapeutics (ASCPT) held a two-day satellite session dedicated to discussing the challenges of conducting clinical trials in patient populations of limited…
DownloadHow much do we know about adherence to biometric monitoring technologies (BioMeTs) in clinical trials?
Very often, suboptimal adherence to data collection procedures and/or a study intervention is a cause of a failed clinical trial. Recently, Koneksa’s Chief Scientific Officer, Dr. Elena Izmailova, who is…
Download